Significance of heart failure in patients with pneumonia – Comparison of BNP and echocardiography

T. Rikimaru (Fukuoka, Japan)

Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections
Session: Treatment and risk factors in lower respiratory tract infections
Session type: E-Communication Session
Number: 5197
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Rikimaru (Fukuoka, Japan). Significance of heart failure in patients with pneumonia – Comparison of BNP and echocardiography. Eur Respir J 2010; 36: Suppl. 54, 5197

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Usefulness of serum (S) and pleural fluid (PF) levels of pro-brain natriuretic peptide (Pro-BNP) in the diagnosis of pleural transudates due to congestive heart failure (CHF)
Source: Eur Respir J 2006; 28: Suppl. 50, 581s
Year: 2006

Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in community-acquired pneumonia – Results from the German competence network CAPNETZ
Source: Annual Congress 2011 - Severity, comorbidities and outcomes in community-acquired pneumonia
Year: 2011

Prognostic value of pulmonary function testing in idiopathic pulmonary hypertension – The most relevant differences between survivors and non-survivors in three-years observation study
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012

Prognostic value of echocardiography, BNP and cardiac troponin I (cTnI) in normotensive patients with pulmonary embolism
Source: Eur Respir J 2005; 26: Suppl. 49, 271s
Year: 2005

The characterization of diastolic function of the right ventricle in patients with COPD combined with congestive heart failure (CHF)
Source: International Congress 2014 – Predictors
Year: 2014


The role of amino-terminal pro-brain natriuretic peptide (NT-proBNP in clinical evaluation of patient with acute exacerbation chronic obstructive pulmonary disease
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014

Pathophysiology of hypoxemia in IPAH – On the crossroads of respiratory and circulatory dysfunction
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010


Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure.
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020


Predictors for developing hypoxic respiratory failure in COPD – A 3-year follow-up
Source: Annual Congress 2011 - Physiological basis of respiratory disease
Year: 2011


Effect of noninvasive ventilation (NIV) on left ventricular (LV) function, B-type natriuretic peptide (BNP) and markers of systemic inflammation in patients with refractory heart failure
Source: Eur Respir J 2006; 28: Suppl. 50, 188s
Year: 2006

Diagnosis on community-acquired pneumonia (CAP) in patients with congestive heart failure (CHF)
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017


Admission due to heart failure and pulmonary function testing: is there a COPD?
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021


B-type natriuretic peptide (BNP) in COPD patients with acute respiratory failure (ARF)
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010

Assessment of serum B-natriuretic peptide(BNP) in elderly patients of lung disease without cor pulmonale or CHF
Source: Eur Respir J 2003; 22: Suppl. 45, 440s
Year: 2003

Left ventricular dysfunction with pulmonary pypertension – Cause vs. association
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010

Heart size and heart dysfunction in COPD – role of hyperinflation
Source: Annual Congress 2009 - Functional insights into COPD
Year: 2009


The rehabilitative treatment by Free-aspireÒ can reduce pulmonary hypertension in patients with post- cardiac surgery heart failure. Hemodynamic evaluation of echocardiographic parameters
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010

Non-invasive ventilation (NIV) in acute respiratory failure in a respiratory intermediate unit care (RICU) – Characterization and predictors of failure
Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure
Year: 2011

Acute hemodynamic effects of non-invasive ventilation (NIV) in patients with exacerbation of congestive heart failure (CHF)
Source: Eur Respir J 2005; 26: Suppl. 49, 550s
Year: 2005

Outcome analysis of ‘do not resuscitate‘ versus ‘full resuscitation‘ patients with an acute exacerbation of COPD treated with noninvasive ventilation in a pulmonary unit
Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure
Year: 2011